Title:
Adjunctive use of mitomycin C in endoscopic revision dacryocystorhinostomy
Authors:
O. Görgülü , S. Özdemir , F. F. Görgülü , A. Altn , T. Selçuk and Y. Akba
Institutions:
Department of Otorhinolaryngology,Adana Numune Education and Research Hospital,Adana, Turkey; 2D epartment of Otorhinolaryngology, Cukurova University School of Medici4e, Adana, Turkey; Department of Radiology, Adana Numune Education and Research Hospital5 Adana, Turkey; Department of Ophthalmology, Adana Numune Education and Research Hospital, Adana, Turkey; Adana Galeria ENT Hospital, Adana, Turkey
Keywords:
Endoscopic dacryocystorhinostomy; external dacryocystorhinostomy, nasolacrimal duct obstruction; mitomycin C; revision; epiphora; dacryocystitis; unsuccessful lacrimal surgery; failure
Pages:
123 - 126
Abstract:
Adjunctive use of mitomycin C in endoscopic revision dacryocystorhinostomy. Objectives: Success rates for revision dacryocystorhinostomy (DCR) are lower than primary DCR. Scarring of the sac may limit the surgeons abili- ty to achieve good nasal and lacrimal mucosa apposition. The aims of this study were to assess the long term safety and efficacy of intra-operative use of adjunctive mitomycin C (MMC) treatment in endoscopic revision DCR surgery over 12-24 (mean 17) months. Methodology: This was a prospective, nonrandomized consecutive case series that included 20 adult patients (20 eyes) with failed primary external DCR who underwent revision surgery under assisted local anaesthesia. During revision endoscopic DCR, intra-operative adjunctive MMC (0.2 mg/mL) was applied to the osteotomy site of the lacrimal sac and scar tissue surrounding the surgical osteum for 5 minutes. Results: The surgical success rate was determined based on the patency of the nasolacrimal system by irrigation and resolution of patient symptoms. Endoscopic revision DCR surgery with MMC was successful in 90% of cases (18 of 20 cases). No adverse effects (eg, abnormal nasal bleeding, mucosal necrosis, infection) or any other surgical adverse events were observed. Conclusions: Adjunctive intra-operative MMC application with endoscopic DCR surgery had a good success rate in patients with nasolacrimal duct obstruction that required revision surgery. Further large, double blind, placebo con- trolled, randomized studies are needed to confirm these findings.
Issue:
Vol. 8, 2012, 2nd trimester


Download:
Adjunctive use of mitomycin C in endoscopic revision dacryocystorhinostomy